AQR Arbitrage’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-352,451
Closed -$26M 453
2018
Q1
$26M Sell
352,451
-54,391
-13% -$4.07M 0.3% 69
2017
Q4
$28.7M Sell
406,842
-10,954
-3% -$790K 0.34% 70
2017
Q3
$26.1M Sell
417,796
-48,402
-10% -$2.87M 0.28% 85
2017
Q2
$26.8M Buy
466,198
+58,164
+14% +$3.42M 0.29% 94
2017
Q1
$24.8M Sell
408,034
-3,497
-0.8% -$198K 0.28% 95
2016
Q4
$22.6M Sell
411,531
-6,482
-2% -$311K 0.23% 105
2016
Q3
$19.3M Buy
418,013
+62,805
+18% +$2.65M 0.19% 121
2016
Q2
$12.1M Buy
+355,208
New +$11.1M 0.13% 148

Other funds holding NGVT

AQR Arbitrage's NGVT Position: Q2 2018 in Review

AQR Arbitrage sold out of Ingevity (NGVT) in Q2 2018, closing a stake of 352,451 shares — an estimated $26M sold.

AQR Arbitrage first reported a position in NGVT in Q2 2016 and held it in 8 quarters. The position peaked at $28.7M in Q4 2017. 309 funds tracked by Wall St. Rank hold NGVT as of Q2 2018.

  • AQR Arbitrage reported no remaining Ingevity position as of Q2 2018 after selling out during the quarter.
  • AQR Arbitrage sold 352,451 Ingevity shares in Q2 2018, an estimated $26M.
  • AQR Arbitrage first reported a position in Ingevity in Q2 2016 and held it in 8 quarters.
  • AQR Arbitrage's Ingevity position peaked at $28.7M in Q4 2017.
  • 309 funds tracked by Wall St. Rank held Ingevity as of Q2 2018.

Based on AQR Arbitrage's 13F filing for Q2 2018, filed 14 Aug 2018.